Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7698911 | 1.00 | MAPT (0.38) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL5702811 | 0.82 | MAPT (0.49) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL5702812 | 0.82 | MAPT (0.49) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL2631175 | 0.81 | MAPT (0.55) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL78464 | 0.79 | MAPT (0.44) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL7701708 | 0.77 | MAPT (0.45) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL7701706 | 0.77 | MAPT (0.45) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL17891885 | 0.75 | HCAR2 (0.37) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL17891884 | 0.75 | HCAR2 (0.37) | MAPTHCAR2ALDH1A1TTRDPP4 | |
| SCHEMBL17243241 | 0.72 | ATM (0.44) | MAPTHCAR2ALDH1A1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1056716-B1 | CYCLOHEXANEDIOLE DERIVATIVES | BASILEA PHARMACEUTICA AG (CH) | 2002-12-11 | — | — | EP | disclosed |
| US-6184422-B1 | TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA | HOFFMAN-LA ROCHE INC. | 2001-02-06 | — | — | US | disclosed |
| EP-1056716-A1 | CYCLOHEXANEDIOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-12-06 | — | — | EP | disclosed |
| WO-1999043646-A1 | CYCLOHEXANEDIOLE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-09-02 | — | — | WO | disclosed |